AlphaCentric Life Sciences And Healthcare Fund NVO Holdings History
AlphaCentric Life Sciences and Healthcare Fund's Novo Nordisk AS Holding Summary
As of 2025-03-31, AlphaCentric Life Sciences and Healthcare Fund held - shares of Novo Nordisk AS(NVO), totaling N/A. This investment constitutes 0% of their stock portfolio, and AlphaCentric Life Sciences and Healthcare Fund now holds 0% of the outstanding Novo Nordisk AS(NVO) stock.
The initial trade took place in 2024Q4. And since then AlphaCentric Life Sciences and Healthcare Fund has made 1 purchases of NVO, at an average price of $107.98, for a total of 23,334.00 shares. In addition, there have been 1 sales at an average price of $82.59 for 23,334.00 shares. Based on historical transaction data and NVO's current price of $70.73, AlphaCentric Life Sciences and Healthcare Fund's estimated gain on his NVO holdings is $-592,450.26, reflecting a -23.51% gain to date.
AlphaCentric Life Sciences and Healthcare Fund NVO ($70.73) Holding Chart
AlphaCentric Life Sciences and Healthcare Fund NVO ($70.73) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
